Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer



Total Raised


Date of IPO


Market Cap


Stock Price


About Progenity

Progenity is a biotechnology company with a presence in women's health molecular testing and a pipeline of proprietary tests and therapeutic applications. Progenity has a portfolio of technologies and tests for pre-eclampsia, genetic carrier testing, inheritable cancer genetics, liquid biopsy and noninvasive prenatal testing (NIPT), all designed to support clinicians in providing excellent patient care.

Progenity Headquarter Location

4330 La Jolla Village Drive Suite 200

San Diego, California, 92122,

United States


Latest Progenity News

Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of Gastroenterology

Jan 11, 2022

The abstract is now available on the BWGE 2022 website . About Progenity Progenity, Inc. is a biotechnology company innovating in the fields of women’s health, gastrointestinal health and oral biotherapeutics. Progenity applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies. For more information visit , or follow the company on LinkedIn or Twitter . Investor Contact:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Progenity

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Progenity is included in 5 Expert Collections, including Women's Health & Wellness.


Women's Health & Wellness

1,445 items

Startups focused on providing products and services catering to women's health and wellbeing.


Medical Devices

7,889 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance



1,213 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Progenity Patents

Progenity has filed 51 patents.

The 3 most popular patent topics include:

  • Gastrointestinal tract disorders
  • Histopathology
  • Digestive system
patents chart

Application Date

Grant Date


Related Topics




Molecular biology, Genetics, Transcription factors, DNA, Rare diseases


Application Date


Grant Date



Related Topics

Molecular biology, Genetics, Transcription factors, DNA, Rare diseases



Progenity Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Progenity Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.